Related Experiment Video
Updated: Jul 15, 2026

09:43
Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair
Published on: February 24, 2016
Scar tissue graft as a filler for soft tissue augmentation
Yakup Sariguney1, Yucel Hakki Demir, Reha Yavuzer
1Department of Plastic Reconstructive and Aesthetic Surgery, Gazi University Faculty of Medicine, Besevler, Ankara 06500, Turkey. mail@yakupsariguney.com
Aesthetic Plastic Surgery
|May 9, 2007
Summary
Injectable scar tissue offers comparable soft tissue filler results to dermal grafts for up to five months. This study explored scar tissue
Area of Science:
- Regenerative Medicine
- Plastic Surgery
- Biomaterials Science
Background:
- Autogenous tissue grafts are standard for soft tissue augmentation in facial contouring and reconstruction.
- Dermal grafts offer longevity, while fat grafts are favored for ease of use.
- Existing scar tissue presents a potential alternative filler material.
Purpose of the Study:
- To evaluate the efficacy of injectable scar tissue as a soft tissue filler.
- To compare scar tissue grafts with dermal grafts for volumetric retention and histological characteristics.
- To explore the clinical implications of using scar tissue for augmentation.
Main Methods:
- Scar tissue was created and harvested from Wistar rats.
- Harvested scar and dermal tissues were depithelialized and minced.
- Grafts were injected into recipient sites and evaluated volumetrically and histologically at 1, 3, and 5 months.
Main Results:
- Initially, dermal grafts showed significantly higher retention than scar grafts.
- By 3 and 5 months, scar graft volume was comparable to dermal grafts.
- Scar grafts primarily consisted of dense connective tissue, suggesting fibrous tissue formation contributes to filler volume.
Conclusions:
- Injectable scar tissue demonstrates comparable volumetric results to dermal grafts up to five months post-transplantation.
- Scar tissue forms fibrous tissue, providing adequate filler volume, though neovascularization may be less robust than in dermal grafts.
- This finding has potential clinical applications for patients requiring simultaneous scar revision and soft tissue augmentation.
More Related Videos
Related Concept Videos
Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...

